Steroid-Induced Osteoporosis
Steroid-induced osteoporosis is a form of secondary bone loss triggered by long-term use of corticosteroids, commonly prescribed for inflammatory and autoimmune diseases. These medications interfere with the bone remodeling process by inhibiting osteoblast activity, increasing osteoclast activity, and impairing calcium absorption. As a result, bone density can decline rapidly, often within the first six months of therapy.
Most individuals with steroid-induced osteoporosis do not experience symptoms until they suffer a fracture, commonly in the spine, which may cause sudden back pain or height reduction. If not addressed early, this condition can lead to chronic pain and disability.
Diagnosis involves obtaining a baseline bone density scan (DEXA) before or soon after starting corticosteroid therapy. Periodic monitoring is recommended to detect changes over time. Blood tests may also be used to evaluate vitamin D and calcium levels.
Treatment focuses on minimizing steroid dosage to the lowest effective level, supplementing with calcium and vitamin D, and initiating antiresorptive medications such as bisphosphonates or denosumab at the onset of long-term steroid use. Patients at high risk may also benefit from newer bone-building agents.
Preventive measures include early screening, lifestyle changes, and close monitoring during corticosteroid therapy. Physicians and patients must remain vigilant to prevent avoidable fractures and long-term skeletal complications.
Causes & Risk Factors
The primary cause of this condition is the use of glucocorticoids at doses of 5 mg or more of prednisone (or its equivalent) daily for longer than three months. These medications suppress the function of bone-building cells (osteoblasts), accelerate the breakdown of bone by osteoclasts, and interfere with calcium metabolism. Individuals with other risk factors for osteoporosis—such as older age, postmenopausal status, low body weight, smoking, or a family history of fractures—are at even higher risk when placed on long-term steroid therapy.
Symptoms
Steroid-induced osteoporosis usually does not cause any symptoms until a fracture occurs. In many cases, the first sign of the condition is a vertebral compression fracture, which may present as sudden back pain or a noticeable loss in height. Hip fractures may also occur, especially in older adults, and are often associated with serious complications. Because the disease progresses silently, regular screening is critical.
Diagnosis
Diagnosis begins with a baseline bone mineral density test (DEXA scan) shortly after steroid therapy is initiated. Follow-up scans are usually recommended every 6 to 12 months to monitor changes in bone mass. In addition, blood tests may be used to check levels of vitamin D, calcium, phosphate, and markers of bone turnover. A full review of the patient’s medical history, steroid dosage, and duration of use is necessary to assess risk.
Treatment Options
Effective treatment of steroid-induced osteoporosis involves both addressing the underlying need for steroid therapy and protecting the bones. Whenever possible, the steroid dose should be minimized, and the treatment duration limited. Patients should be started on calcium and vitamin D supplements early, and those at moderate to high risk of fracture may require antiresorptive medications like bisphosphonates or denosumab. In certain high-risk patients, especially those with previous fractures or rapid bone loss, anabolic agents like teriparatide may be prescribed to stimulate new bone formation. Lifestyle modifications, including resistance exercises, smoking cessation, and alcohol moderation, also play a critical role.
Prevention Tips
Preventing steroid-induced osteoporosis requires proactive planning. Before initiating long-term steroid treatment, patients should undergo a bone health assessment. Calcium (1,000–1,200 mg daily) and vitamin D (800–1,000 IU daily) should be started at the same time as steroid therapy. Fall prevention strategies, weight-bearing exercise, and regular monitoring with DEXA scans are essential to minimize the risk of fractures. Education for patients and healthcare providers about this often-overlooked complication can lead to earlier intervention and improved outcomes.